Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
ADHD Drugs May Not Help Kids Get Better Grades: Study September 28, 2016 Martha Garcia Add Your Comments Despite claims to the contrary by pharmaceutical companies, ADHD medications do not appear to help children finish their homework or get better grades at school, according to the findings of new research. . In a study published this month in the Journal of Consulting and Clinical Psychology, researchers from the Center for Children and Families at Florida International University in Miami note that children given a long-acting drug for attention deficit hyperactivity disorder (ADHD) typically did not have any bette grades or concentration at school, compared to children who were given behavioral therapy. Researchers evaluated a group of 75 children between the ages of 5 and 12 years old. Families were randomly selected to participate in either a behavioral treatment group, long-acting stimulant group or a control group. The patients in the behavioral treatment group were given homework-focused parent training along with a daily report card. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Children were excluded if they had autism, mental health disorders or medical issues which made them unable to tolerate stimulant drugs. Children with ADHD typically suffer academic impairment and difficulty completing homework. Drug companies often market stimulants, both long and short acting such as Adderall and Ritalin, to children with ADHD, claiming it will help them focus, and thus perform better at school. The children attended a summer school program with classes every weekday from 8 a.m. to 5 p.m. for 8 weeks. Doctors worked with children for two weeks to determine the correct dose of drugs. Children received the stimulant for three weeks then were switched to the placebo or vice versa. The behavioral therapy group was given six, two-hour group sessions for the first two weeks, then individual half-hour sessions for the next two weeks. Children who took the stimulants had no improvement on homework completion or accuracy compared to placebo. The study did not specifically say which stimulant was given; however, long-acting stimulants include Adrenal XR, Concerta, Dexedrine, and Spansule. Adderall and Ritalin are both short-acting stimulants. Children who received behavioral treatment completed 10% to 13% more homework problems and completed eight percent more problems accurately than children who received medication or were in the control group. Researchers say this amounts to the difference between getting a passing grade of C with behavioral help, compared to an average failing grade of F without intervention. “Despite being advertised as beneficial, long-acting stimulant medication is not recommended for the remediation of homework problems at this time,” wrote study authors. ADHD Drug Risks A study published by the U.S. Centers for Disease Control and Prevention (CDC) last year indicated more children are being treated for ADHD with medication than with behavioral therapy, despite medical experts advising behavioral therapy as the first line of treatment for kids with the disorder. About 40% of children with ADHD are treated with medication alone. The side effects of some ADHD drugs like Ritalin, Dexedrine, and Concerta have been linked to an increased risk of heart problems, weight gain and childhood diabetes, and other health risks. About 15% of all high school-age children in the United States have been diagnosed with ADHD, but some experts say that number should be closer to 5%. One early advocate of stimulate treatment for children with ADHD, Dr. Keith Conners of Duke University, said that the rate of children now being diagnosed with ADHD and placed on drug treatments is “preposterous” and called ADHD an epidemic manufactured by drug companies. Conners and others say that the inflated diagnoses and prescriptions are the result of a 20 year effort by the pharmaceutical industry to cash in on concerned parents hoping that poor grades and typical childhood behavior can be cured with drugs. Tags: Adderall, ADHD, ADHD Drugs, Childrens Drugs, Concerta, Ritalin More Lawsuit Stories Pedestrian Deaths in U.S. Have Risen Nearly 50% Over the Past Decade: GHSA March 17, 2025 Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 March 14, 2025 At Least 8 Lawsuits Over Oxbryta Filed Against Pfizer, Global Blood Therapeutics March 14, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: 3 days ago) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024) Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 4 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025) Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 5 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 March 14, 2025
Mediation To Discuss Settling Covidien Hernia Mesh Lawsuits Set for March 31 Through April 4 (Posted: 3 days ago) Parties involved in Covidien hernia mesh lawsuits indicate they are ready to meet with a mediator in a couple weeks to begin potential settlement negotiations. MORE ABOUT: HERNIA MESH LAWSUITCovidien Hernia Mesh Settlement Talks To Get Underway After Parties Select Mediator Next Week (02/19/2025)Discovery Deadlines in Covidien Hernia Mesh Lawsuits Extended by MDL Judge (12/12/2024)Court Appoints Bard Hernia Mesh Settlement Special Masters To Implement “Intensive” Process To Resolve Claims (11/22/2024)
Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (Posted: 4 days ago) A federal judge has outlined the schedule for preparing a group of hair relaxer lawsuits for early bellwether trials, which will not go before a jury until at least 2027. MORE ABOUT: HAIR RELAXER LAWSUITSynthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)Hair Relaxer Wrongful Death Lawsuit Links Fatal Endometrial Cancer to Chemical Straightener Use (03/04/2025)Hair Relaxer Lawsuit Settlement Talks Begin With Focus on Finding Mediator, Parties Report (02/11/2025)
Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (Posted: 5 days ago) A BioZorb tissue marker lawsuit representing five women from across the country claims that the recalled implant was defectively designed, resulting in a recall and numerous complications. MORE ABOUT: BIOZORB LAWSUITBioZorb Attorneys Propose Leadership Structure for Lawsuits Over Recalled Tissue Marker (03/05/2025)Schedule Leading to First BioZorb Lawsuit Jury Trial in September 2025 Outlined By Court (02/21/2025)Judge Indicates BioZorb Recall and Warning Letter Do Not Warrant Reopening Discovery in Bellwether Cases (02/12/2025)